The new drug ordinance appears to have certain definite advantages over the generic scheme. A central Licensing Board and a Registration Board will be set up to regulate manufacture, sale and registration of drugs. Without registration drugs shall not be imported, manufactured, stored distributed or sold in the country. The pharmaceutical firms shall have to furnish a detailed information about their products, efficacy, quality, safety and side effects. These Boards have been invested with administrative power to deal effectively with substandard and ineffective drugs.